Arrowhead Research Corporation(ARWR)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ARWR Arrowhead Research Corporation

已收盘 05-14 16:00:00 EDT

22.91

+0.85

+3.85%

盘后22.91

+0.000.00%

19:55 EDT

最高24.22	最低22.39	成交量204.60万
今开22.39	昨收22.06	日振幅8.30%
总市值28.45亿	流通市值27.32亿	总股本1.24亿
成交额4,704万	换手率1.72%	流通股本1.19亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"ARWR","market":"US","secType":"STK","nameCN":"Arrowhead Research Corporation","latestPrice":22.91,"timestamp":1715716800000,"preClose":22.06,"halted":0,"volume":2045991,"hourTrading":{"tag":"盘后","latestPrice":22.91,"preClose":22.91,"latestTime":"19:55 EDT","volume":279263,"amount":6396282.092377,"timestamp":1715730949564},"delay":0,"floatShares":119244280,"shares":124200230,"eps":-4.233567,"marketStatus":"已收盘","marketStatusCode":5,"change":0.85,"latestTime":"05-14 16:00:00 EDT","open":22.39,"high":24.2199,"low":22.39,"amount":47038654.800186,"amplitude":0.082951,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-4.233567,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1715760000000},"adr":0,"listingDate":740203200000,"adjPreClose":22.06,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":22.39,"preClose":22.06,"latestTime":"09:29 EDT","volume":476,"amount":10646.359752,"timestamp":1715693399999},"postHourTrading":{"tag":"盘后","latestPrice":22.91,"preClose":22.91,"latestTime":"19:55 EDT","volume":279263,"amount":6396282.092377,"timestamp":1715730949564},"volumeRatio":1.496633,"optionData":{"bulkOrders":[{"symbol":"ARWR","call":true,"expireDate":1726804800000,"strike":"35.0","timestamp":1715695800369,"price":1.75,"volume":4360,"amount":763000,"type":"+"},{"symbol":"ARWR","call":true,"expireDate":1734670800000,"strike":"27.0","timestamp":1715710840745,"price":4.010000228881836,"volume":2000,"amount":802000,"type":"-"}]}},"requestUrl":"/m/hq/s/ARWR","defaultTab":"news","newsList":[{"id":"2435751699","title":"Arrowhead Pharmaceuticals, Inc.盘中异动 快速拉升5.12%报23.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2435751699","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2435751699?lang=zh_cn&edition=full","pubTime":"2024-05-14 21:34","pubTimestamp":1715693668,"startTime":"0","endTime":"0","summary":"北京时间2024年05月14日21时34分，Arrowhead Pharmaceuticals, Inc.股票出现波动，股价大幅拉升5.12%。Arrowhead Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Arrowhead Pharmaceuticals, Inc.公司简介：Arrowhead Pharmaceuticals Inc是一家美国生物技术公司。消息层面，截至21时34分，《大摩：维持Arrowhead Pharma评级，由持股观望调整至持股观望评级, 目标价由36.00美元调整至27.00美元。》资讯为影响Arrowhead Pharmaceuticals, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051421342987e87cd4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051421342987e87cd4&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2435330840","title":"大摩：维持Arrowhead Pharma(ARWR.US)评级，由持股观望调整至持股观望评级, 目标价由36.00美元调整至27.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2435330840","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2435330840?lang=zh_cn&edition=full","pubTime":"2024-05-14 00:45","pubTimestamp":1715618707,"startTime":"0","endTime":"0","summary":"大摩：维持Arrowhead Pharma(ARWR.US)评级，由持股观望调整至持股观望评级, 目标价由36.00美元调整至27.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051400450887633cf7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051400450887633cf7&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2434525138","title":"Arrowhead Pharmaceuticals, Inc.盘中异动 股价大跌5.40%报23.39美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2434525138","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2434525138?lang=zh_cn&edition=full","pubTime":"2024-05-10 22:05","pubTimestamp":1715349932,"startTime":"0","endTime":"0","summary":"北京时间2024年05月10日22时05分，Arrowhead Pharmaceuticals, Inc.股票出现异动，股价大幅跳水5.40%。截至发稿，该股报23.39美元/股，成交量15.1445万股，换手率0.12%，振幅7.85%。Arrowhead Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.37%。Arrowhead Pharmaceuticals, Inc.公司简介：Arrowhead Pharmaceuticals Inc是一家美国生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240510220533792707dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240510220533792707dc&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2434855383","title":"美国研究综述-Cerence、Epam Systems、Progyny","url":"https://stock-news.laohu8.com/highlight/detail?id=2434855383","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2434855383?lang=zh_cn&edition=full","pubTime":"2024-05-10 20:39","pubTimestamp":1715344798,"startTime":"0","endTime":"0","summary":"    路透5月10日 - 华尔街证券分析师周五调整了对几家美国上市公司的评级和目标价，其中包括 Cerence、Epam Systems 和 Progyny。要闻  * Cerence Inc   ：富国银行将其评级从 \"增持 \"下调至 \"等权重\"。* Epam Systems Inc   ：丰业银行将其评级从 \"跑赢大市 \"下调至 \"行业表现\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2434023434","title":"Arrowhead Pharmaceuticals Inc 公布截至三月份的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2434023434","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2434023434?lang=zh_cn&edition=full","pubTime":"2024-05-10 05:02","pubTimestamp":1715288546,"startTime":"0","endTime":"0","summary":"   * Arrowhead Pharmaceuticals Inc   公布的截至三月份的季度调整后每股亏损为1.02美元，低于去年同期的每股收益45美分。14 位分析师对该季度的平均预期是每股亏损 16 美分。华尔街预期为每股-95 美分至 3.27 美元。* Arrowhead Pharmaceuticals Inc 的股价本季度下跌了 11.8%，今年迄今为止下跌了 17.6%。* 生物技术和医学研究同行的平均一致建议也是 \"买入\"。华尔街对 Arrowhead Pharmaceuticals Inc 的 12 个月目标价中位数为 55.00 美元。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2426909794","title":"Arrowhead Pharmaceuticals, Inc.盘中异动 股价大跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426909794","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426909794?lang=zh_cn&edition=full","pubTime":"2024-04-10 21:46","pubTimestamp":1712756811,"startTime":"0","endTime":"0","summary":"北京时间2024年04月10日21时46分，Arrowhead Pharmaceuticals, Inc.股票出现波动，股价急速下跌5.03%。截至发稿，该股报24.93美元/股，成交量5.083万股，换手率0.04%，振幅1.75%。Arrowhead Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.37%。其相关个股中，Adial Pharmaceuticals, Inc、Tc Biopharm  Plc C/Wts 10/02/2028 、Jaguar Health, Inc.涨幅较大，Adial Pharmaceuticals, Inc、Silo Pharma, Inc.、Abvc Biopharma, Inc.较为活跃，换手率分别为1289.04%、70.50%、26.74%，振幅较大的相关个股有Adial Pharmaceuticals, Inc、Calidi Biotherapeutics, Inc.、Silo Pharma, Inc.，振幅分别为61.06%、31.96%、24.26%。Arrowhead Pharmaceuticals, Inc.公司简介：Arrowhead Pharmaceuticals Inc是一家美国生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041021465187e7f4d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041021465187e7f4d3&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421045723","title":"Arrowhead Pharmaceuticals, Inc.盘中异动 股价大涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2421045723","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421045723?lang=zh_cn&edition=full","pubTime":"2024-03-21 21:41","pubTimestamp":1711028461,"startTime":"0","endTime":"0","summary":"北京时间2024年03月21日21时41分，Arrowhead Pharmaceuticals, Inc.股票出现异动，股价急速上涨5.04%。Arrowhead Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.71%。Arrowhead Pharmaceuticals, Inc.公司简介：Arrowhead Pharmaceuticals Inc是一家美国生物技术公司。消息层面，截至21时41分，Arrowhead Pharmaceuticals, Inc.股票正面舆情新闻比例100%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240321214101861e019b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240321214101861e019b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419934747","title":"Arrowhead Pharmaceuticals, Inc.盘中异动 临近收盘股价大跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2419934747","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419934747?lang=zh_cn&edition=full","pubTime":"2024-03-15 03:34","pubTimestamp":1710444887,"startTime":"0","endTime":"0","summary":"北京时间2024年03月15日03时34分，Arrowhead Pharmaceuticals, Inc.股票出现波动，股价急速下跌5.04%。Arrowhead Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.02%。其相关个股中，Revolution Medicines Inc C/Wts 17/12/2026 、Nkgen Biotech Inc C/Wts 31/05/2028、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，知临集团、Psyence Biomedical Ltd.、Novabay Pharmaceuticals, Inc.较为活跃，换手率分别为838.02%、237.79%、186.93%，振幅较大的相关个股有Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Psyence Biomedical Ltd.、知临集团，振幅分别为110.40%、87.49%、76.91%。Arrowhead Pharmaceuticals, Inc.公司简介：Arrowhead Pharmaceuticals Inc是一家美国生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403150334477a4cc27e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403150334477a4cc27e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2418350194","title":"Arrowhead Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2418350194","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2418350194?lang=zh_cn&edition=full","pubTime":"2024-03-11 21:36","pubTimestamp":1710164174,"startTime":"0","endTime":"0","summary":"北京时间2024年03月11日21时36分，Arrowhead Pharmaceuticals, Inc.股票出现波动，股价急速下跌5.29%。截至发稿，该股报31.68美元/股，成交量8.4224万股，换手率0.07%，振幅2.90%。Arrowhead Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.44%。其相关个股中，Biocardia Inc C/Wts 06/08/2024、Tc Biopharm  Plc、Tc Biopharm  Plc C/Wts 10/02/2028 涨幅较大，Tc Biopharm  Plc、180 Life Sciences Corp.、Sonnet Biotherapeutics Holdings, Inc.较为活跃，换手率分别为802.63%、154.35%、71.77%，振幅较大的相关个股有Tc Biopharm  Plc、Equillium, Inc.、Aprea Therapeutics, Inc.，振幅分别为26.89%、14.23%、13.66%。Arrowhead Pharmaceuticals, Inc.公司简介：Arrowhead Pharmaceuticals Inc是一家美国生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031121361487e77c54&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031121361487e77c54&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2411636842","title":"Arrowhead Pharmaceuticals Inc盘中异动 早盘股价大跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2411636842","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2411636842?lang=zh_cn&edition=full","pubTime":"2024-02-13 22:41","pubTimestamp":1707835268,"startTime":"0","endTime":"0","summary":"北京时间2024年02月13日22时41分，Arrowhead Pharmaceuticals Inc股票出现异动，股价急速下挫5.08%。截至发稿，该股报30.62美元/股，成交量6.5407万股，换手率0.05%，振幅1.55%。Arrowhead Pharmaceuticals Inc股票所在的生物技术行业中，整体跌幅为0.76%。其相关个股中，Biodexa Pharmaceuticals Plc、180 Life Sciences Corp C/Wts 07/11/2025、Protagenic Therapeutics Inc涨幅较大，Biodexa Pharmaceuticals Plc、Adial Pharmaceuticals Inc、Kintara Therapeutics Inc较为活跃，换手率分别为314.49%、89.09%、50.08%，振幅较大的相关个股有Fresh2 Group Limited、Bioxcel Therapeutics Inc、Larimar Therapeutics Inc，振幅分别为19.48%、19.48%、18.90%。Arrowhead Pharmaceuticals Inc公司简介：Arrowhead Pharmaceuticals Inc是一家美国生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402132241087a4377ed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402132241087a4377ed&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2409227492","title":"Arrowhead Pharmaceuticals Inc盘中异动 早盘快速跳水5.15%报31.49美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2409227492","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2409227492?lang=zh_cn&edition=full","pubTime":"2024-02-07 22:32","pubTimestamp":1707316332,"startTime":"0","endTime":"0","summary":"北京时间2024年02月07日22时32分，Arrowhead Pharmaceuticals Inc股票出现波动，股价大幅跳水5.15%。截至发稿，该股报31.49美元/股，成交量6.1272万股，换手率0.05%，振幅3.10%。Arrowhead Pharmaceuticals Inc股票所在的生物技术行业中，整体跌幅为0.02%。其相关个股中，Jasper Therapeutics Inc C/Wts 24/09/2026 、Biodexa Pharmaceuticals Plc、Invivo Therapeutics Holding Corp涨幅较大，Biodexa Pharmaceuticals Plc、Invivo Therapeutics Holding Corp、Altamira Therapeutics Ltd较为活跃，换手率分别为130.85%、73.69%、38.66%，振幅较大的相关个股有Invivo Therapeutics Holding Corp、Viracta Therapeutics Inc、Equillium Inc，振幅分别为25.00%、12.94%、12.14%。Arrowhead Pharmaceuticals Inc公司简介：Arrowhead Pharmaceuticals Inc是一家美国生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024020722321281761b20&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024020722321281761b20&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2409222518","title":"BUZZ-Arrowhead Pharma 第一季度亏损超预期，业绩下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2409222518","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2409222518?lang=zh_cn&edition=full","pubTime":"2024-02-07 22:09","pubTimestamp":1707314977,"startTime":"0","endTime":"0","summary":"    2月7日 - ** 药物开发商Arrowhead Pharmaceuticals   股价盘前下跌5.7%至31.3美元** Arrowhead报告称， ，第一季度 净亏损为1.24美元/股，分析师预计为亏损82美分/股--LSEG数据** ARWR 的收入比去年同期骤降 94%，降至 360 万美元。** 9月至12月的收入主要来自合作伙伴葛兰素史克  和武田  ，而去年同期 的收入来自强生公司的杨森部门、武田、Horizon和安进  。** 截至12月31日，Arrowhead公司拥有5820万美元的现金和现金等价物、 ** 截至周二收盘，该公司股价在过去 12 个月中下跌了 ~1","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2409216232","title":"美国研究综述-皇冠控股公司、沃特斯公司、西部制药服务公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2409216232","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2409216232?lang=zh_cn&edition=full","pubTime":"2024-02-07 15:56","pubTimestamp":1707292591,"startTime":"0","endTime":"0","summary":"    路透2月7日 - 华尔街证券分析师周三调整了对几家美国上市公司的评级和目标价，其中包括空气产品和皇冠控股公司、沃特斯公司和西部制药服务公司。* 沃特斯公司  ：Evercore ISI将目标价从315美元上调至320美元             * West Pharmaceutical Services Inc   ：杰富瑞将目标价从 \"持有 \"上调至 \"买入 以下是路透周三报道的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2409530772","title":"Arrowhead Pharmaceuticals Inc 公布截至 12 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2409530772","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2409530772?lang=zh_cn&edition=full","pubTime":"2024-02-07 07:34","pubTimestamp":1707262464,"startTime":"0","endTime":"0","summary":"   * Arrowhead Pharmaceuticals Inc   报告，截至12月底的季度调整后每股亏损1.24美元，低于去年同期的每股收益-39美分。11 位分析师对该季度的平均预期是每股亏损 82 美分。华尔街预期为每股亏损 1.12 美元至-29 美分。* Arrowhead Pharmaceuticals Inc 公布的本季度每股收益为亏损 1.24 美元。* 该公司一季度亏损 1.3286 亿美元。* 本季度，Arrowhead Pharmaceuticals Inc 的股价上涨了 4.6%。华尔街对 Arrowhead Pharmaceuticals Inc 的 12 个月目标价中位数为 51.00 美元。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2408950534","title":"Arrowhead Pharmaceuticals Inc    预计每股亏损 82 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2408950534","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2408950534?lang=zh_cn&edition=full","pubTime":"2024-02-03 05:52","pubTimestamp":1706910736,"startTime":"0","endTime":"0","summary":"   * Arrowhead Pharmaceuticals Inc    将于2月6日公布截至2023年12月31日的财报，预计该公司的季度收入将出现下降。* 根据LSEG的数据，8位分析师的平均预期显示，这家总部位于加利福尼亚州帕萨迪纳的公司的营收预计将从去年同期的6255万美元下降52.8%，至2951.1万美元。* LSEG 分析师对 Arrowhead Pharmaceuticals Inc 的平均预期是每股亏损 82 美分。* 华尔街对 Arrowhead Pharmaceuticals Inc 的 12 个月目标价中位数为 51.00 美元，高于上一交易日 32.19 美元的收盘价。2月2日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2404360394","title":"美国研究综述-伯灵顿商店、Carrols 餐厅、Mastec","url":"https://stock-news.laohu8.com/highlight/detail?id=2404360394","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2404360394?lang=zh_cn&edition=full","pubTime":"2024-01-18 02:52","pubTimestamp":1705517520,"startTime":"0","endTime":"0","summary":"    路透1月17日 - 华尔街证券分析师周三调整了对几家美国上市公司的评级和目标价，其中包括伯灵顿百货公司、Carrols Restaurant Group 和 Mastec。要点 * Ambrx Biopharma Cayman Inc   ：贝雅将其评级下调至中性 * Burlington Stores Inc   ：Piper Sandler将其评级从中性上调至增持  * Carrols Restaurant Group Inc   ：Stephens将其评级从 \"增持 \"下调至 \"等权重\"。* Mastec Inc   ：贝尔德将其评级从 \"跑赢大盘 \"下调至 \"中性\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2402747285","title":"Arrowhead Pharmaceuticals Inc盘中异动 临近收盘股价大跌5.04%报37.46美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2402747285","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2402747285?lang=zh_cn&edition=full","pubTime":"2024-01-12 04:51","pubTimestamp":1705006289,"startTime":"0","endTime":"0","summary":"北京时间2024年01月12日04时51分，Arrowhead Pharmaceuticals Inc股票出现异动，股价大幅下跌5.04%。截至发稿，该股报37.46美元/股，成交量138.2万股，换手率1.12%，振幅5.20%。Arrowhead Pharmaceuticals Inc股票所在的生物技术行业中，整体跌幅为0.08%。其相关个股中，Atreca Inc、Cassava Sciences Inc C/Wts 15/11/2024、Surrozen Inc C/Wts 01/08/2031 涨幅较大，Atreca Inc、Clearmind Medicine Inc、Neximmune Inc较为活跃，换手率分别为491.09%、327.63%、86.05%，振幅较大的相关个股有Sab Biotherapeutics Inc C/Wts 22/10/2026 、Ys Biopharma Co Ltd C/Wts 15/03/2028 、Cassava Sciences Inc C/Wts 15/11/2024，振幅分别为170.95%、115.32%、111.45%。Arrowhead Pharmaceuticals Inc公司简介：Arrowhead Pharmaceuticals Inc是一家美国生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240112045129861ca0c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240112045129861ca0c7&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2402483829","title":"BUZZ-美国银行上调 Arrowhead Pharma 的股票交易价格后，该公司股价上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2402483829","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2402483829?lang=zh_cn&edition=full","pubTime":"2024-01-10 23:12","pubTimestamp":1704899564,"startTime":"0","endTime":"0","summary":"** 称该公司拥有充足的资金，可以积极研究主要的肺部和心血管代谢管线项目** 美国银行重申对 2024 年和 2025 年管线候选项目关键试验数据的 \"买入 \"评级 ** 增加 ARWR 的公开募股，使公司目前拥有约 8.5 亿美元现金** 该公司最近以 28.50 美元的价格出售了  1579 万股股票，筹集了 4.5 亿美元资金用于研发和公司一般开支** 14 家券商中有 10 家将该股评为 \"买入 \"或更高评级，4 家建议 \"持有\"；他们的预测中值为 51 美元** 2023 年 ARWR 股价下跌 24.6","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2401586229","title":"美国研究综述-Agilon Health、戴尔科技、Fabrinet","url":"https://stock-news.laohu8.com/highlight/detail?id=2401586229","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2401586229?lang=zh_cn&edition=full","pubTime":"2024-01-08 20:50","pubTimestamp":1704718259,"startTime":"0","endTime":"0","summary":"    路透1月8日 - 华尔街证券分析师周一调整了对几家美国上市公司的评级和目标价，其中包括 Agilon Health、戴尔科技和 Fabrinet。要闻  * Agilon Health Inc   ：加拿大皇家银行将目标价从23美元下调至11美元 * Brown & Brown Inc   ：加拿大皇家银行将其评级从 \"行业表现 \"上调至 \"跑赢大盘\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.arrowheadpharma.com","stockEarnings":[{"period":"1week","weight":-0.1232},{"period":"1month","weight":-0.1069},{"period":"3month","weight":-0.2627},{"period":"6month","weight":-0.1833},{"period":"1year","weight":-0.439},{"period":"ytd","weight":-0.2791}],"compareEarnings":[{"period":"1week","weight":0.0084},{"period":"1month","weight":0.0197},{"period":"3month","weight":0.0543},{"period":"6month","weight":0.1584},{"period":"1year","weight":0.2656},{"period":"ytd","weight":0.0959}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Arrowhead Pharmaceuticals, Inc.最初于1989年在南达科他州注册成立，后在特拉华州重新注册成立。该公司开发药物，通过沉默疾病的基因来治疗疑难杂症。使用广泛的RNA化学组合和高效的递送模式，该公司的疗法触发RNA干扰机制，以诱导目标基因的快速、深度和持久敲低。该公司已将资源集中于在跨越多个治疗领域的多个动物模型中独家利用其高水平药理活性的疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.45,"avgChangeRate":0.005728},{"month":2,"riseRate":0.5,"avgChangeRate":-0.002685},{"month":3,"riseRate":0.55,"avgChangeRate":0.072176},{"month":4,"riseRate":0.45,"avgChangeRate":0.022654},{"month":5,"riseRate":0.3,"avgChangeRate":-0.001082},{"month":6,"riseRate":0.578947,"avgChangeRate":0.019834},{"month":7,"riseRate":0.578947,"avgChangeRate":0.054947},{"month":8,"riseRate":0.421053,"avgChangeRate":0.002555},{"month":9,"riseRate":0.526316,"avgChangeRate":0.050964},{"month":10,"riseRate":0.45,"avgChangeRate":-0.042406},{"month":11,"riseRate":0.5,"avgChangeRate":0.037176},{"month":12,"riseRate":0.45,"avgChangeRate":0.061288}],"exchange":"NASDAQ","name":"Arrowhead Research Corporation","nameEN":"Arrowhead Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Arrowhead Research Corporation(ARWR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Arrowhead Research Corporation(ARWR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Arrowhead Research Corporation,ARWR,Arrowhead Research Corporation股票,Arrowhead Research Corporation股票老虎,Arrowhead Research Corporation股票老虎国际,Arrowhead Research Corporation行情,Arrowhead Research Corporation股票行情,Arrowhead Research Corporation股价,Arrowhead Research Corporation股市,Arrowhead Research Corporation股票价格,Arrowhead Research Corporation股票交易,Arrowhead Research Corporation股票购买,Arrowhead Research Corporation股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Arrowhead Research Corporation(ARWR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Arrowhead Research Corporation(ARWR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}